cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n.1
title: 3-methylbenzaldehyde
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367].
 The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]:
 InChI descriptor[cheminf_000113]: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3, and canonical SMILES descriptor[cheminf_000007]: O=Cc1cccc(c1)C, and by the IUPAC name[cheminf_000107]: 3-methylbenzaldehyde.
 
 The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]:
 
 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-37687

 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]:
 Melting point descriptor[CHEMINF_000256]: 
 Boiling point descriptor[CHEMINF_000257]: 
 Refractive index descriptor[CHEMINF_000253]:

 The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]:
 
 CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000604 | heteronuclear single quantum coherence (HSQC)
 
 CHMO:0000599 | correlation spectroscopy (COSY)
 
 CHMO:0000601 | heteronuclear multiple bond coherence (HMBC)
 
 The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: 

 Used ontologies:
 CHEBI - Chemical Entities of Biological Interest
 CHEMINF - chemical information ontology (information entities about chemical entities)
 CHMO - Chemical Methods Ontology
 OBI - Ontology for Biomedical Investigations
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000596
title: distortionless enhancement with polarization transfer (DEPT) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000599
title: correlation spectroscopy (COSY) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for correlation spectroscopy (COSY)
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000596.1
title: distortionless enhancement with polarization transfer (DEPT) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000601
title: heteronuclear multiple bond coherence (HMBC) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for heteronuclear multiple bond coherence (HMBC)
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 13C NMR (100 MHz, Chloroform-d [77.2 ppm], ppm) δ = 192.7 (CH), 139.1 (Cq), 136.6 (Cq), 135.4 (CH), 130.2 (CH), 129.0 (CH), 127.4 (CH), 21.3 (CH3).
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 1H NMR (400 MHz, Chloroform-d [7.26 ppm], ppm) δ = 9.99 (s, 1H), 7.69–7.67 (m, 2H), 7.45–7.40 (m, 2H), 2.43 (s, 3H).
DOI: 10.14272/ovwyeqovudkznu-uhfffaoysa-n/chmo0000604
title: heteronuclear single quantum coherence (HSQC) (3-methylbenzaldehyde)
title: InChI=1S/C8H8O/c1-7-3-2-4-8(5-7)6-9/h2-6H,1H3

description: dataset for heteronuclear single quantum coherence (HSQC)
DOI: 10.5281/zenodo.10404104
title: TARIXDA JANGCHILARNING AXLOQIY-RUHIY TA'LIM-TARBIYA TIZIMI
DOI: 10.5281/zenodo.10404105
title: TARIXDA JANGCHILARNING AXLOQIY-RUHIY TA'LIM-TARBIYA TIZIMI
DOI: 10.5281/zenodo.10404040
title: The v4 16S and 5.8S/ITS4 ITS regions of Hopland soil microcosms

description: Soil was collected from the Buck pasture plot at the Hopland Research and Extension Center (Mendocino County, CA) at a depth of 0–10cm on 10/03/2020. Soil was sieved through a 2.0mm wire mesh. Microcosms were established by adding 206g (+/- 0.5g) of soil to 64oz acid washed and autoclaved mason jars. Each microcosm had one of the following treatments: (1) natural abundance water (diH2O); (2) diH2O + KH2PO4; (3) heavy water (H218O); (4) H218O + KH2PO4 in triplicate (four treatments x three replicates x three timepoints = 36 mason jars). H218O enrichment ranged from 98.06–98.54% and KH2PO4 (for +P treatments) was added to the water and mixed for a final concentration of 50µM. Water was added to each sample slowly and evenly across the soil surface with a syringe to bring the soil up to 30% moisture. Mason jars were sealed with lids that had airtight septa and incubated at room temperature (~23°C).

This dataset represents sequencing of the v4 16S and 5.8S/ITS4 ITS regions of all but 8 samples. Missing samples include: T_2_H218O_P_A, T_3_H2O_A, T_3_H2O_B, T_3_H2O_C, T_3_H2O_P_A, T_3_H2O_P_B, T_3_H2O_P_C, and T_3_H218O_A. Duplicate T0 dry soil was sequenced and 1 water control for a total of 31 samples. Each sample was seqeunced for 16S and ITS for a total of 62 amplicon samples. Each amplicon had paired reads for a total of 124 reads.
DOI: 10.5281/zenodo.10404041
title: The v4 16S and 5.8S/ITS4 ITS regions of Hopland soil microcosms

description: Soil was collected from the Buck pasture plot at the Hopland Research and Extension Center (Mendocino County, CA) at a depth of 0–10cm on 10/03/2020. Soil was sieved through a 2.0mm wire mesh. Microcosms were established by adding 206g (+/- 0.5g) of soil to 64oz acid washed and autoclaved mason jars. Each microcosm had one of the following treatments: (1) natural abundance water (diH2O); (2) diH2O + KH2PO4; (3) heavy water (H218O); (4) H218O + KH2PO4 in triplicate (four treatments x three replicates x three timepoints = 36 mason jars). H218O enrichment ranged from 98.06–98.54% and KH2PO4 (for +P treatments) was added to the water and mixed for a final concentration of 50µM. Water was added to each sample slowly and evenly across the soil surface with a syringe to bring the soil up to 30% moisture. Mason jars were sealed with lids that had airtight septa and incubated at room temperature (~23°C).

This dataset represents sequencing of the v4 16S and 5.8S/ITS4 ITS regions of all but 8 samples. Missing samples include: T_2_H218O_P_A, T_3_H2O_A, T_3_H2O_B, T_3_H2O_C, T_3_H2O_P_A, T_3_H2O_P_B, T_3_H2O_P_C, and T_3_H218O_A. Duplicate T0 dry soil was sequenced and 1 water control for a total of 31 samples. Each sample was seqeunced for 16S and ITS for a total of 62 amplicon samples. Each amplicon had paired reads for a total of 124 reads.
DOI: 10.5281/zenodo.10404110
title: ИСЛОМ ҲУҚУҚИДА ШЕРИКЧИЛИК ШАРТНОМАЛАРИ
DOI: 10.5281/zenodo.10404111
title: ИСЛОМ ҲУҚУҚИДА ШЕРИКЧИЛИК ШАРТНОМАЛАРИ
DOI: 10.6084/m9.figshare.21646560
title: A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic

description: Failure of the Falsified Medicines Directive (FMD) in the UK could mean that substandard and falsified medicines (SFs) enter the supply chain. Does this risk patients’ health? Readiness to implement FMD, and prevalence of SFs vs. regulator detection were assessed. A total of 12,040 primary care pharmacies across England were invited (April 2021–March 2022). Respondent postcodes were used to extract deprivation scores. Information request was placed with the medicine’s agency. Survey findings were used to calculate probability and power of a simulated trial. A total of 208 participants responded: Of the seven who identified SFs, all but one reported it; 61% were ready to implement FMD, 74.1% had adequate resources, 54.8% expected improved patient safety, and 17.8% had ever reported SFs. SFs were prevalent in deprived areas. Bayesian simulation shows 438 (<i>p</i> = 0.030) incidences with a 3% probability of SFs prevalence. The agency identified 15,238 SFs units in the supply chain (2019 and 2020). Results are credible, reliable, and generalisable, with corroborated longitudinal persistence. FMD or equivalent processes need to be urgently reinstated. Deprived children may be more affected. Pharmacists are worried about liability. All health consultations should assess safety, and effectiveness of medicines. Findings should inform policy, systems planning, surveillance, and evaluations.
DOI: 10.6084/m9.figshare.23899655
title: Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis

description: Insomnia is a multi-factorial disorder with conventional treatment options that are not satisfactory for many patients. This metaanalysis analyzed the safety and efficacy of daridorexant. An electronic database search for RCTs was conducted on Medline via PubMed, Cochrane, and Clinicaltrials.gov using the terms ‘Daridorexant,’ ‘RCT,’ ‘Insomnia’ trials evaluating the efficacy and/or safety of daridorexant for insomnia were included. The data were synthesized using Cochrane review manager version 5.4.1. Cochrane risk of bias 2.0 tool and GRADEpro-GDT were used to assess the methodological and evidence quality, respectively. Of 109 searched studies, four trials were included. The risk of treatment-emergent adverse events with 25 mg daridorexant [risk ratio (RR) = 1.12 (0.88, 1.43), <i>p</i> = 0.36; I<sup>2</sup> = 0%] and 50 mg daridorexant [RR = 1.25 (0.88, 1.79), <i>p</i> = 0.22; I<sup>2</sup> = 28%] and serious adverse events with 25 mg [RR = 0.86 (0.23, 3.19), <i>p</i> = 0.82, I<sup>2</sup> = 56%] and 50 mg [RR = 1.32 (0.29, 6.08), <i>p</i> = 0.72, I<sup>2</sup> = 52%] was comparable to placebo [Moderate quality evidence]. Risk of nasopharyngitis was also comparable to placebo. The efficacy parameters like wake after sleep onset, latency to persistent sleep, and subjective total sleep time showed significant improvement with daridorexant. The risk of bias is low for three studies and some concern for one. Daridorexant is a safer and efficacious agent for induction and maintenance of sleep for chronic insomnia. The registration number is CRD42022335233. www.clinicaltrials.gov identifiers are NCT03575104, NCT03545191, NCT03679884, and NCT02839200).
DOI: 10.6084/m9.figshare.21646560.v1
title: A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic

description: Failure of the Falsified Medicines Directive (FMD) in the UK could mean that substandard and falsified medicines (SFs) enter the supply chain. Does this risk patients’ health? Readiness to implement FMD, and prevalence of SFs vs. regulator detection were assessed. A total of 12,040 primary care pharmacies across England were invited (April 2021–March 2022). Respondent postcodes were used to extract deprivation scores. Information request was placed with the medicine’s agency. Survey findings were used to calculate probability and power of a simulated trial. A total of 208 participants responded: Of the seven who identified SFs, all but one reported it; 61% were ready to implement FMD, 74.1% had adequate resources, 54.8% expected improved patient safety, and 17.8% had ever reported SFs. SFs were prevalent in deprived areas. Bayesian simulation shows 438 (<i>p</i> = 0.030) incidences with a 3% probability of SFs prevalence. The agency identified 15,238 SFs units in the supply chain (2019 and 2020). Results are credible, reliable, and generalisable, with corroborated longitudinal persistence. FMD or equivalent processes need to be urgently reinstated. Deprived children may be more affected. Pharmacists are worried about liability. All health consultations should assess safety, and effectiveness of medicines. Findings should inform policy, systems planning, surveillance, and evaluations.
DOI: 10.5281/zenodo.10404118
title: ABSORBSION QURITISH JARAYONIGA TA'SIR QILUVCHI OMILLAR
DOI: 10.5281/zenodo.10404119
title: ABSORBSION QURITISH JARAYONIGA TA'SIR QILUVCHI OMILLAR
DOI: 10.6084/m9.figshare.24862905.v1
title: <b>Widespread cooling of topsoil under nitrogen enrichment and implication for soil carbon flux</b>

description: Here we provide a datasets of soil respiration from field N manipulative experiments studies obtained by integrating literature,including soil temperature,different sites or with diverse vegetation types, N levels, forms or frequencies.
DOI: 10.5281/zenodo.10404127
title: Α-AMINOATSETONITRILLARDA UGLEROD ATOMIDA BORADIGAN TURLI ALKILLASH REAKSIYALARI
DOI: 10.5281/zenodo.10404126
title: Α-AMINOATSETONITRILLARDA UGLEROD ATOMIDA BORADIGAN TURLI ALKILLASH REAKSIYALARI
DOI: 10.25505/fiz.icsd.cc2bk6dj
title: CSD 2161487: Experimental Crystal Structure Determination

description: Related Article: Ying Long, Xuehua Dong, Ling Huang, Hongmei Zeng, Zhien Lin, Guohong Zou|2022|Inorg.Chem.|61|16997|doi:10.1021/acs.inorgchem.2c03266
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c0brh
title: CSD 2175076: Experimental Crystal Structure Determination

description: Related Article: Junyan Li, Alvaro Mayoral, Yoshihiro Kubota, Satoshi Inagaki, Jihong Yu, Osamu Terasaki|2022|Angew.Chem.,Int.Ed.|61|e202211196|doi:10.1002/anie.202211196
description: Related Article: Junyan Li|2022|CSD Communication|||
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c47f6
title: CSD 2178817: Experimental Crystal Structure Determination

description: Related Article: Dominique Laniel, Florian Trybel, Adrien Néri, Yuqing Yin, Andrey Aslandukov, Timofey Fedotenko, Saiana Khandarkhaeva, Ferenc Tasnádi, Stella Chariton, Carlotta Giacobbe, Eleanor Lawrence Bright, Michael Hanfland, Vitali Prakapenka, Wolfgang Schnick, Igor A. Abrikosov, Leonid Dubrovinsky, Natalia Dubrovinskaia|2022|Chem.-Eur.J.|28|e202201998|doi:10.1002/chem.202201998
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c47g7
title: CSD 2178818: Experimental Crystal Structure Determination

description: Related Article: Dominique Laniel, Florian Trybel, Adrien Néri, Yuqing Yin, Andrey Aslandukov, Timofey Fedotenko, Saiana Khandarkhaeva, Ferenc Tasnádi, Stella Chariton, Carlotta Giacobbe, Eleanor Lawrence Bright, Michael Hanfland, Vitali Prakapenka, Wolfgang Schnick, Igor A. Abrikosov, Leonid Dubrovinsky, Natalia Dubrovinskaia|2022|Chem.-Eur.J.|28|e202201998|doi:10.1002/chem.202201998
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c47h8
title: CSD 2178819: Experimental Crystal Structure Determination

description: Related Article: Dominique Laniel, Florian Trybel, Adrien Néri, Yuqing Yin, Andrey Aslandukov, Timofey Fedotenko, Saiana Khandarkhaeva, Ferenc Tasnádi, Stella Chariton, Carlotta Giacobbe, Eleanor Lawrence Bright, Michael Hanfland, Vitali Prakapenka, Wolfgang Schnick, Igor A. Abrikosov, Leonid Dubrovinsky, Natalia Dubrovinskaia|2022|Chem.-Eur.J.|28|e202201998|doi:10.1002/chem.202201998
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c47j9
title: CSD 2178820: Experimental Crystal Structure Determination

description: Related Article: Dominique Laniel, Florian Trybel, Adrien Néri, Yuqing Yin, Andrey Aslandukov, Timofey Fedotenko, Saiana Khandarkhaeva, Ferenc Tasnádi, Stella Chariton, Carlotta Giacobbe, Eleanor Lawrence Bright, Michael Hanfland, Vitali Prakapenka, Wolfgang Schnick, Igor A. Abrikosov, Leonid Dubrovinsky, Natalia Dubrovinskaia|2022|Chem.-Eur.J.|28|e202201998|doi:10.1002/chem.202201998
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c47kb
title: CSD 2178821: Experimental Crystal Structure Determination

description: Related Article: Dominique Laniel, Florian Trybel, Adrien Néri, Yuqing Yin, Andrey Aslandukov, Timofey Fedotenko, Saiana Khandarkhaeva, Ferenc Tasnádi, Stella Chariton, Carlotta Giacobbe, Eleanor Lawrence Bright, Michael Hanfland, Vitali Prakapenka, Wolfgang Schnick, Igor A. Abrikosov, Leonid Dubrovinsky, Natalia Dubrovinskaia|2022|Chem.-Eur.J.|28|e202201998|doi:10.1002/chem.202201998
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.25505/fiz.icsd.cc2c4thv
title: CSD 2179377: Experimental Crystal Structure Determination

description: Related Article: Nazar Zaremba, Kristian Witthaut, Yurii Prots, Mitja Krnel, Ulrich Burkhardt, Zachary Fisk, Yuri Grin, Eteri Svanidze|2022|Inorg.Chem.|61|19695|doi:10.1021/acs.inorgchem.2c01986
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c4xt8
title: CSD 2179480: Experimental Crystal Structure Determination

description: Related Article: Xianji Qiao, Yi Qiu, Junjie Xin, Da Chen, Zili Ma, Alex J. Corkett, Guohong Cai, Guanqun Cai, Shangqing Qu, YuChao Wang, Zhenyu Zhu, Yiman Gao, Zhigang Wang, Richard Dronskowski, Guobao Li, Junliang Sun|2023|Dalton Trans.|52|3971|doi:10.1039/D3DT00384A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c4y2k
title: CSD 2179488: Experimental Crystal Structure Determination

description: Related Article: Xianji Qiao, Yi Qiu, Junjie Xin, Da Chen, Zili Ma, Alex J. Corkett, Guohong Cai, Guanqun Cai, Shangqing Qu, YuChao Wang, Zhenyu Zhu, Yiman Gao, Zhigang Wang, Richard Dronskowski, Guobao Li, Junliang Sun|2023|Dalton Trans.|52|3971|doi:10.1039/D3DT00384A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c4y3l
title: CSD 2179489: Experimental Crystal Structure Determination

description: Related Article: Xianji Qiao, Yi Qiu, Junjie Xin, Da Chen, Zili Ma, Alex J. Corkett, Guohong Cai, Guanqun Cai, Shangqing Qu, YuChao Wang, Zhenyu Zhu, Yiman Gao, Zhigang Wang, Richard Dronskowski, Guobao Li, Junliang Sun|2023|Dalton Trans.|52|3971|doi:10.1039/D3DT00384A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.25505/fiz.icsd.cc2c51n8
title: CSD 2179599: Experimental Crystal Structure Determination

description: Related Article: Yang Liu, Ya-Ping Gong, Shining Geng, Mei-Ling Feng, Despoina Manidaki, Zeyu Deng, Constantinos C. Stoumpos, Pieremanuele Canepa, Zewen Xiao, Wei-Xiong Zhang, Lingling Mao|2022|Angew.Chem.,Int.Ed.|61|e202208875|doi:10.1002/anie.202208875
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2c4y6p
title: CSD 2179492: Experimental Crystal Structure Determination

description: Related Article: Xianji Qiao, Yi Qiu, Junjie Xin, Da Chen, Zili Ma, Alex J. Corkett, Guohong Cai, Guanqun Cai, Shangqing Qu, YuChao Wang, Zhenyu Zhu, Yiman Gao, Zhigang Wang, Richard Dronskowski, Guobao Li, Junliang Sun|2023|Dalton Trans.|52|3971|doi:10.1039/D3DT00384A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.